Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: Analysis of a Brazilian population

Cancer Investigation

Volumn 26, Issue 1, 2008, Pages 74-80

  Neto, Brasil Silva ^a   Koff, Walter J ^a   Biolchi, Vanderlei ^b   Brenner, Cleber ^a   Biolo, Karlo D ^a   Spritzer, Poli Mara ^b   Brum, Ilma S ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Androgen receptor; Polymorphism; Prostate cancer; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; DNA FRAGMENT; GENOMIC DNA;

ADULT; AGED; ARTICLE; BRAZIL; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE REPEAT; POPULATION GENETICS; POPULATION RISK; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; BRAZIL; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 37849017532     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701638251     Document Type: Article

References (31)

1. Grönberg H. Prostate cancer epidemiology. The Lancet 2003, 361, 859-864.
2. Nelson, W.G.; De Marzom A.M.; Isaacs, W.B. Prostate cancer. New England Journal of Medicine 2003, 349, 366-381.
3. What are the key statistics about prostate cancer? American Cancer Society. Reference Information. Available at: http://www.cancer.org. Accessed 03/03/2006.
4. Câncer de próstata: consenso. Instituto Nacional do Câncer. Ministério da Saúde, Brasil. 2002
5. INCA (Instituto Nacional do Câncer). Ministério da Saúde, Brasil. Estimativa de incidência e mortalidade por câncer no Brasil para 2005. Available at: http://www.inca.gov.br. Accessed 11/21/2005.
6. Carter, H.B.; Partin, A.W. Diagnosis and staging of prostate cancer. In: Walsh: Campbell's Urology 8th edition: WB Saunders; 2002. p. 3055-3064
7. Balic, I.; Graham, S.T.; Troyer, D.A.; Higgins, B.A.; Pollock, B.H.; Johnson-Pais, T.L.; Thompson, I.M.; Leach, R.J. Androgen receptor length polymorphism associated with prostate cancer risk in hispanic men. The Journal of Urology 2002, 168, 2245-2248.
8. Coughlin, S.S.; Hall, H.L. A review of genetic polymorphisms and prostate cancer risk. Annals of Epidemiology 2002, 12, 182-196.
9. Nelson, K.A.; Witte, J.S. Androgen receptor CAG repeats and prostate cancer. American Journal of Epidemiology 2002, 155, 883-890.
10. Linja, M.J.; Visakorpi, T. Alterations of androgen receptor in prostate cancer. Journal of Steroid Biochemistry & Molecular Biology 2004, 92, 255-264.
11. Tsujimoto, Y.; Takakuwa, T.; Takayama, H.; Nishimura, K.; Okuyama, A.; Aozasa, K.; Nomomura, N. In Situ Shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. The Prostate 2004, 58, 283-290.
12. Platz, E.A.; Leitzmann, M.F.; Rifai, N.; Kantoff, P.W.; Chen, Y.C.; Stampfer, M.J.; Willet, W.C.; Giovanucci, E. Sex Steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiology, Biomarkers & Prevention 2005, 14(5), 1262-1269.
13. Kantoff, P.; Giovanucci, E.; Brown, M. The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer. Biochimica et Biophysica Acta 1998, 1378, C1-C5.
14. Mahtre, A.N.; Trifiro, M.A.; Kaufman, M.; Kazemi-Esfarjani, P.; Figlewicz, D.; Rouleau, G.; Pinsky, L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 1993, 5(2), 184-188.
15. Sartor, O.; Zheng, Q.; Eastham, JÁ. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 1999, 53(2), 378-380.
16. Giovanucci, E.; Stampfer, M.J.; Krithivas, K.; Brown, M.; Brufsky, A.; Talcott, J.; Hennekens, C.H.; Kantoff, P.W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proceedings of the National Academy of Sciences 1997, 94, 3320-3323.
17. Ingles, S.A.; Ross, R.K.; Yu, M.C.; Irvine, R.A.; La Pera, G.; Haile, R.W.; Coetzee, G.A. Association of prostate cancer risk with genetic polymorphism in vitamin D receptor and androgen receptor. Journal of National Cancer Institute 1997, 89(2), 166-170.
18. Correa-Cerro, L.; Wohr, G.; Haussler, J.; Berthon, P.; Drelon, E.; Mangin, P.; Fournier, P.; Cussenot, O.; Kraus, P.; Just, W. et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German Population. European Journal of Human Genetics 1999, 7(3), 357-362.
19. Bratt, O.; Borg, A.; Kristoffersson, U.; Lundgren, R.; Zhang, Q.X.; Olsson, H. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. British Journal of Cancer 1999, 81(4), 672-676.
20. Santos, M.L.; Sarkis, A.S.; Nishimoto, I.N.; Nagai, M.A. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population. Cancer Detection and Prevention 2003, 27, 321-326.
21. Hsing, A.W.; Gao, Y.T.; Wu, G.; Wang, X.; Deng, J.; Chen, Y.L. et al. Polymorphic CAG and GGN Repeat Lengths in the Androgen Receptor Gene and Prostate Cancer Risk: A population-based Case-Control Study in China. Cancer Research 2000, 60, 5111-5116.
22. Stanford, J.L.; Just, J.J.; Gibbs, M.; Wicklund, K.G.; Neal, C.L.; Blumenstein, B.A.; Ostrander, E.A. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Research 1997, 57(6), 1194-1198.
23. Hakimi, J.M.; Schoenberg, M.P.; Rondinelli, R.H.; Piantadosi, S.; Barrack, E.R. Androgen Receptor Variants with Short Glutamine or Glycine repeats may identify unique subpopulations of men with prostate cancer. Clinical Cancer Research 1997, 3(9), 1599-608.
24. Kittles, R.A.; Young, D.; Weinrich, S.; Hudson, J.; Argyropoulos, G.; Ukoli, F. Extent of linkage Disequilibrium Between the Androgen Receptor Gene CAG and GGC Repeats in Human Populations: Implications for Prostate Cancer Risk. Human Genetics 2001, 109, 253-261.
25. Zeegers, M.P.; Kiemeney, L.A.L.M.; Nieder, A.M.; Ostrer, H. How strong is the association between CAG e GGN repeat length polimorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiology, Biomarkers & Prevention 2004, 13(11), 1765-1771.
26. Freedman, M.L.; Pearce, C.L.; Penney, K.L.; Hirschhorn, J.N.; Kolonel, L.N.; Henderson, B.E.; Altshuler, D. Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. American Journal of Human Genetics 2005, 76, 82-90.
27. Parra, F.C.; Amado, R.C.; Lambertucci, J.R.; Rocha, J.; Antunes, C.M.; Pena, S.D.J. Color and genomic ancestry in brazilians. Proccedings of the National Academy of Sciences of the United States of America 2003, 100(1), 177-182.
28. Marrero, A.R.; Leite, F.P.N.; Carvalho, B.A.; Peres, L.M., Kommers, T.C.; Cruz, I.M.; Salzano, F.M.; Ruiz-Linares, A.; Da Silva Júnior, W.A.; Bortolini, M.C. Heterogeneity of the genome ancestry of individuals classified as White in the state of Rio Grande do Sul, Brazil. American Journal of Human Biology 2005, 17(4), 496-506.
29. Chang, B.L.; Zheng, S.L.; Hawkins, G.A.; Isaacs, S.D.; Wiley, K.E.; Turner, A. et al. Polymorphic GGC Repeats in the Androgen Receptor Gene are Associated with Hereditary and Sporadic Prostate Cancer Risk. Human Gnetics 2002, 110, 122-129
30. Chen, C.; Lambarzi, N.; Weiss, N.S.; Etzioni, R.; Dightman, D.A.; Barnett, M.; Di Tommaso, D.; Goodman, G. Androgen receptor polymorphism and the incidence of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2002, 11, 1033-1040.
31. Ferlin, A.; Bartolini, L.; Rizzo, G.; Roverato, A.; Garolla, A.; Foresta, C. Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Molecular Human Reproduction 2004, 10(6), 417-421.